- Home
- ADIL vs TNON Comparison
ADIL vs TNON Comparison
Compare ADIL & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADIL
- TNON
- Stock Information
- Founded
- ADIL 2010
- TNON 2012
- Country
- ADIL United States
- TNON United States
- Employees
- ADIL N/A
- TNON N/A
- Industry
- ADIL Biotechnology: Pharmaceutical Preparations
- TNON Medical Specialities
- Sector
- ADIL Health Care
- TNON Health Care
- Exchange
- ADIL Nasdaq
- TNON Nasdaq
- Market Cap
- ADIL 4.8M
- TNON 4.8M
- IPO Year
- ADIL 2018
- TNON 2022
- Fundamental
- Price
- ADIL $0.79
- TNON $1.39
- Analyst Decision
- ADIL Strong Buy
- TNON Strong Buy
- Analyst Count
- ADIL 1
- TNON 2
- Target Price
- ADIL $8.00
- TNON $16.00
- AVG Volume (30 Days)
- ADIL 172.8K
- TNON 95.9K
- Earning Date
- ADIL 03-31-2025
- TNON 03-11-2025
- Dividend Yield
- ADIL N/A
- TNON N/A
- EPS Growth
- ADIL N/A
- TNON N/A
- EPS
- ADIL N/A
- TNON N/A
- Revenue
- ADIL N/A
- TNON $3,315,000.00
- Revenue This Year
- ADIL N/A
- TNON $29.03
- Revenue Next Year
- ADIL N/A
- TNON $100.29
- P/E Ratio
- ADIL N/A
- TNON N/A
- Revenue Growth
- ADIL N/A
- TNON 38.30
- 52 Week Low
- ADIL $0.72
- TNON $1.35
- 52 Week High
- ADIL $4.17
- TNON $15.79
- Technical
- Relative Strength Index (RSI)
- ADIL 40.52
- TNON 32.21
- Support Level
- ADIL $0.76
- TNON $1.35
- Resistance Level
- ADIL $0.85
- TNON $1.59
- Average True Range (ATR)
- ADIL 0.05
- TNON 0.11
- MACD
- ADIL 0.01
- TNON 0.01
- Stochastic Oscillator
- ADIL 50.77
- TNON 14.81
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants, and 3) SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.